Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19

Amrita Chatterjee1, Rajdeep Saha1, Arpita Mishra2

  • 1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India.

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause significant cardiovascular damage, including myocarditis. This review assesses COVID-19

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to widespread organ damage, particularly affecting the cardiovascular system.
  • Mechanisms of cardiovascular injury include ACE2 downregulation, hypoxia, and systemic inflammation, complicating COVID-19 disease and leading to conditions like multisystem inflammatory syndrome.
  • While treatments and vaccines exist, the long-term cardiovascular consequences of COVID-19 remain insufficiently understood.

Purpose of the Study:

  • To comprehensively review and synthesize existing data on the cardiovascular effects of COVID-19.
  • To examine the impact of COVID-19 on patients with pre-existing cardiovascular comorbidities.
  • To investigate reported cardiovascular complications following SARS-CoV-2 vaccination.

Main Methods:

  • Systematic survey and summarization of available literature on COVID-19 and cardiovascular health.
  • Analysis of case reports detailing post-immunization cardiovascular events.
  • Review of studies focusing on COVID-19's impact on cardiac function and inflammatory markers.

Main Results:

  • COVID-19 is associated with diverse cardiovascular complications, including myocardial injury and inflammatory syndromes.
  • Pre-existing cardiovascular conditions may exacerbate COVID-19's impact on heart health.
  • Rare cardiovascular adverse events have been reported post-vaccination, requiring further investigation.

Conclusions:

  • COVID-19 poses a significant threat to cardiovascular health, necessitating ongoing monitoring and research.
  • Understanding the long-term cardiovascular sequelae of infection and vaccination is crucial for patient management.
  • Further studies are needed to fully elucidate the relationship between COVID-19, vaccination, and cardiovascular outcomes.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
85
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
81
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
42
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
34
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
42